World News: 12:35 GMT Friday 12th July 2019. [RAFARMA PHARMACEUTICALS INC via Globe Newswire via SPi World News]
Ljubljana, Slovenia, July 12, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Mr. Srečo Bojt shall remain as a company Director.
Vladimir G. Dolgolenko, who resides in Slovenia, received his degrees from the Moscow State Foreign Language University (1984) and Moscow Aviation Institute (1989). Mr. Dolgolenko has earned a Masters degree in Economics and is fluent in English, Russian, Spanish and Swedish.
Mr. Dolgolenko started his career in the Russian Ministry of Fuel Industry in the Foreign Relations Department in the Crude Oil Production and Processing Section. In 1991, he was appointed Executive Vice President of RosCanA and Vice President of Roscana Holdings, a U.S. corporation. In the 1990s while residing in the U.S., he was an exclusive representative of PetroFac Engineering (), a then Texas company, for the territories of Eastern Europe and Russia. Since then Mr. Vladimir Dolgolenko has occupied top executive positions in a number of US, European and other international businesses.
Mr. Dolgolenko has major management expertise in the development and implementation of biotechnologies in degraded soil processing and recultivation, as well as the monetization of new biotechnologies in agriculture, crude oil refineries, and petroleum waste processing.
Mr. Dolgolenko brings to Rafarma tremendous management experience that will refine Rafarma’s processes, enter new markets, and raise revenues toward a tremendous increase in shareholder value.
Globe Newswire: 12:35 GMT Friday 12th July 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.